Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author: Hossain, Ragib
Other Authors: Talukder, Mesbah
Format: Thesis
Language:English
Published: Brac University 2024
Subjects:
Online Access:http://hdl.handle.net/10361/23148
id 10361-23148
record_format dspace
spelling 10361-231482024-06-05T21:06:12Z Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS) Hossain, Ragib Talukder, Mesbah School of Pharmacy, Brac University Onychomycosis Hepatotoxicity Acute Kidney Injury Onychomycosis Hepatotoxicology Acute renal failure This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from the PDF version of thesis. Includes bibliographical references (pages 24-28). Infections caused by fungi typically affect the skin, nails, and lungs but they can also penetrate the skin, infect the organs and spread throughout the body but research has found that dermatophytosis of the toenails and fingernails, known as onychomycosis, is more challenging to treat with medication than fungal infections of other body parts. Due to their high cure rates and safety profiles, azole antifungals replaced topical treatments in treating onychomycosis. However, studies suggest these medicines cause Hepatotoxicity and Acute kidney injury. In this study information from the FAERS database is analyzed using a reporting odds ratio (ROR) to identify potential danger signs. Hepatotoxicity Reporting odds ratio for drug's were, Voriconazole 8.16 (6.29, 10.60) > Itraconazole 3.98 (1.99, 7.96) > Posaconazole 3.23 (1.62, 6.47). Additionally, Acute kidney Injury Reporting odds ratio for selected drug were, Voriconazole 0.46 (0.33, 0.65) > Posaconazole 0.37 (0.19, 0.71) > Itraconazole 0.10 (0.03, 0.40). Ragib Hossain B. Pharmacy 2024-06-05T06:08:23Z 2024-06-05T06:08:23Z ©2023 2023-02 Thesis ID 19146002 http://hdl.handle.net/10361/23148 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 40 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Onychomycosis
Hepatotoxicity
Acute Kidney Injury
Onychomycosis
Hepatotoxicology
Acute renal failure
spellingShingle Onychomycosis
Hepatotoxicity
Acute Kidney Injury
Onychomycosis
Hepatotoxicology
Acute renal failure
Hossain, Ragib
Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
author2 Talukder, Mesbah
author_facet Talukder, Mesbah
Hossain, Ragib
format Thesis
author Hossain, Ragib
author_sort Hossain, Ragib
title Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
title_short Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
title_full Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
title_fullStr Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
title_full_unstemmed Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
title_sort hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of onychomycosis: pharmacovigilance study of fda adverse event reporting system data (faers)
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/23148
work_keys_str_mv AT hossainragib hepatotoxicityandacutekidneyinjuryassociationswithitraconazolevoriconazoleandposaconazoleinthetreatmentofonychomycosispharmacovigilancestudyoffdaadverseeventreportingsystemdatafaers
_version_ 1814309816990957568